Home > News > Investors Turn On Patent-Challenged Tessera
March 4th, 2008
Investors Turn On Patent-Challenged Tessera
Abstract:
Tessera Technologies took a beating from investors on Tuesday after the Patent Office rejected one of its key patents.
San Jose-based Tessera Technologies (nasdaq: TSRA - news - people ) said the U.S. Patent and Trademark Office rejected its already heavily licensed 627 patent. The nanotechnology company said the "issued patent is presumed to be valid, intact and enforceable" while it appeals the ruling, a process that takes twenty-four months on average. Investors were shaken by the tainted patent. The company fell 39.0%, or $8.99, to close at $14.07.
On Feb. 29, the Patent Office rejected every tenet of the patent. Competitor Siliconware had sought a reevaluation of five lucrative Tessera patents. This group of patents have been challenged in litigation before. Tessera has reported that the contentious patents have resulted in more than $250 million in cumulative licensing earnings.
Source:
forbes.com
Bookmark:
| Related News Press |
News and information
Quantum computer improves AI predictions April 17th, 2026
Flexible sensor gains sensitivity under pressure April 17th, 2026
A reusable chip for particulate matter sensing April 17th, 2026
Detecting vibrational quantum beating in the predissociation dynamics of SF6 using time-resolved photoelectron spectroscopy April 17th, 2026
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Chip Technology
A reusable chip for particulate matter sensing April 17th, 2026
Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||